Investigations are being carried out by Johnson Fistel, PLLP in San Diego starting December 15, 2025, regarding derivative claims associated with aTyr Pharma, Inc. (NASDAQ: ATYR) involving suspected breaches of fiduciary duties related to the Phase 3 EFZO-FIT clinical trial disclosures. The class action in question pertains to...